Logo image of KRN.DE

KRONES AG (KRN.DE) Stock Fundamental Analysis

FRA:KRN - Deutsche Boerse Ag - DE0006335003 - Common Stock - Currency: EUR

142.8  +3.8 (+2.73%)

Fundamental Rating

6

KRN gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 106 industry peers in the Machinery industry. KRN scores excellent on profitability, but there are some minor concerns on its financial health. KRN has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

KRN had positive earnings in the past year.
In the past year KRN had a positive cash flow from operations.
Of the past 5 years KRN 4 years were profitable.
KRN had a positive operating cash flow in each of the past 5 years.
KRN.DE Yearly Net Income VS EBIT VS OCF VS FCFKRN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

Looking at the Return On Assets, with a value of 5.83%, KRN is in the better half of the industry, outperforming 75.47% of the companies in the same industry.
Looking at the Return On Equity, with a value of 14.45%, KRN belongs to the top of the industry, outperforming 82.08% of the companies in the same industry.
KRN has a better Return On Invested Capital (11.58%) than 86.79% of its industry peers.
The Average Return On Invested Capital over the past 3 years for KRN is in line with the industry average of 8.48%.
The 3 year average ROIC (10.37%) for KRN is below the current ROIC(11.58%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.83%
ROE 14.45%
ROIC 11.58%
ROA(3y)5.11%
ROA(5y)3.35%
ROE(3y)13.07%
ROE(5y)8.54%
ROIC(3y)10.37%
ROIC(5y)N/A
KRN.DE Yearly ROA, ROE, ROICKRN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

Looking at the Profit Margin, with a value of 5.25%, KRN is in the better half of the industry, outperforming 64.15% of the companies in the same industry.
In the last couple of years the Profit Margin of KRN has grown nicely.
KRN has a Operating Margin of 7.09%. This is comparable to the rest of the industry: KRN outperforms 58.49% of its industry peers.
KRN's Operating Margin has improved in the last couple of years.
The Gross Margin of KRN (52.57%) is better than 70.75% of its industry peers.
In the last couple of years the Gross Margin of KRN has remained more or less at the same level.
Industry RankSector Rank
OM 7.09%
PM (TTM) 5.25%
GM 52.57%
OM growth 3Y13.3%
OM growth 5Y31.4%
PM growth 3Y10.38%
PM growth 5Y85.26%
GM growth 3Y0.06%
GM growth 5Y0.84%
KRN.DE Yearly Profit, Operating, Gross MarginsKRN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), KRN is creating some value.
KRN has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, KRN has about the same amount of shares outstanding.
The debt/assets ratio for KRN has been reduced compared to a year ago.
KRN.DE Yearly Shares OutstandingKRN.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
KRN.DE Yearly Total Debt VS Total AssetsKRN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

The Debt to FCF ratio of KRN is 0.01, which is an excellent value as it means it would take KRN, only 0.01 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of KRN (0.01) is better than 100.00% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that KRN is not too dependend on debt financing.
KRN has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. KRN outperforms 97.17% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Altman-Z N/A
ROIC/WACC1.63
WACC7.09%
KRN.DE Yearly LT Debt VS Equity VS FCFKRN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

KRN has a Current Ratio of 1.36. This is a normal value and indicates that KRN is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of KRN (1.36) is worse than 62.26% of its industry peers.
A Quick Ratio of 1.10 indicates that KRN should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.10, KRN perfoms like the industry average, outperforming 50.94% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 1.1
KRN.DE Yearly Current Assets VS Current LiabilitesKRN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

6

3. Growth

3.1 Past

KRN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.60%, which is quite impressive.
KRN shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 96.42% yearly.
KRN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.42%.
Measured over the past years, KRN shows a small growth in Revenue. The Revenue has been growing by 5.98% on average per year.
EPS 1Y (TTM)26.6%
EPS 3Y25.19%
EPS 5Y96.42%
EPS Q2Q%15.38%
Revenue 1Y (TTM)14.42%
Revenue growth 3Y13.35%
Revenue growth 5Y5.98%
Sales Q2Q%13.06%

3.2 Future

The Earnings Per Share is expected to grow by 12.18% on average over the next years. This is quite good.
Based on estimates for the next years, KRN will show a small growth in Revenue. The Revenue will grow by 6.04% on average per year.
EPS Next Y18.02%
EPS Next 2Y16.09%
EPS Next 3Y14.61%
EPS Next 5Y12.18%
Revenue Next Year8.08%
Revenue Next 2Y7.33%
Revenue Next 3Y7.1%
Revenue Next 5Y6.04%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
KRN.DE Yearly Revenue VS EstimatesKRN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
KRN.DE Yearly EPS VS EstimatesKRN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 15.71, the valuation of KRN can be described as correct.
Compared to the rest of the industry, the Price/Earnings ratio of KRN indicates a somewhat cheap valuation: KRN is cheaper than 68.87% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of KRN to the average of the S&P500 Index (27.30), we can say KRN is valued slightly cheaper.
KRN is valuated correctly with a Price/Forward Earnings ratio of 12.08.
KRN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. KRN is cheaper than 61.32% of the companies in the same industry.
KRN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.76.
Industry RankSector Rank
PE 15.71
Fwd PE 12.08
KRN.DE Price Earnings VS Forward Price EarningsKRN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, KRN is valued a bit cheaper than 66.98% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, KRN is valued a bit cheaper than 63.21% of the companies in the same industry.
Industry RankSector Rank
P/FCF 17.52
EV/EBITDA 6.78
KRN.DE Per share dataKRN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of KRN may justify a higher PE ratio.
A more expensive valuation may be justified as KRN's earnings are expected to grow with 14.61% in the coming years.
PEG (NY)0.87
PEG (5Y)0.16
EPS Next 2Y16.09%
EPS Next 3Y14.61%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.84%, KRN has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.89, KRN pays a bit more dividend than its industry peers.
KRN's Dividend Yield is slightly below the S&P500 average, which is at 2.37.
Industry RankSector Rank
Dividend Yield 1.84%

5.2 History

The dividend of KRN has a limited annual growth rate of 5.29%.
Dividend Growth(5Y)5.29%
Div Incr Years1
Div Non Decr Years4
KRN.DE Yearly Dividends per shareKRN.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

24.24% of the earnings are spent on dividend by KRN. This is a low number and sustainable payout ratio.
KRN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP24.24%
EPS Next 2Y16.09%
EPS Next 3Y14.61%
KRN.DE Yearly Income VS Free CF VS DividendKRN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M
KRN.DE Dividend Payout.KRN.DE Dividend Payout, showing the Payout Ratio.KRN.DE Dividend Payout.PayoutRetained Earnings

KRONES AG

FRA:KRN (7/9/2025, 1:50:09 PM)

142.8

+3.8 (+2.73%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-09 2025-05-09/bmo
Earnings (Next)07-30 2025-07-30
Inst Owners20.81%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap4.51B
Analysts81.18
Price Target159.35 (11.59%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.84%
Yearly Dividend2.2
Dividend Growth(5Y)5.29%
DP24.24%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-4.43%
Min EPS beat(2)-7.42%
Max EPS beat(2)-1.44%
EPS beat(4)1
Avg EPS beat(4)6.57%
Min EPS beat(4)-18.73%
Max EPS beat(4)53.89%
EPS beat(8)3
Avg EPS beat(8)2.47%
EPS beat(12)7
Avg EPS beat(12)9.22%
EPS beat(16)11
Avg EPS beat(16)12.7%
Revenue beat(2)1
Avg Revenue beat(2)-0.14%
Min Revenue beat(2)-0.92%
Max Revenue beat(2)0.64%
Revenue beat(4)3
Avg Revenue beat(4)0.37%
Min Revenue beat(4)-0.92%
Max Revenue beat(4)1.67%
Revenue beat(8)3
Avg Revenue beat(8)-0.6%
Revenue beat(12)7
Avg Revenue beat(12)0.62%
Revenue beat(16)9
Avg Revenue beat(16)0.64%
PT rev (1m)5.05%
PT rev (3m)5.26%
EPS NQ rev (1m)-1.1%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)1.59%
Revenue NQ rev (1m)-1.98%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.07%
Valuation
Industry RankSector Rank
PE 15.71
Fwd PE 12.08
P/S 0.83
P/FCF 17.52
P/OCF 10.16
P/B 2.27
P/tB 3.2
EV/EBITDA 6.78
EPS(TTM)9.09
EY6.37%
EPS(NY)11.82
Fwd EY8.28%
FCF(TTM)8.15
FCFY5.71%
OCF(TTM)14.06
OCFY9.85%
SpS172.73
BVpS62.82
TBVpS44.56
PEG (NY)0.87
PEG (5Y)0.16
Profitability
Industry RankSector Rank
ROA 5.83%
ROE 14.45%
ROCE 15.97%
ROIC 11.58%
ROICexc 15.32%
ROICexgc 22.37%
OM 7.09%
PM (TTM) 5.25%
GM 52.57%
FCFM 4.72%
ROA(3y)5.11%
ROA(5y)3.35%
ROE(3y)13.07%
ROE(5y)8.54%
ROIC(3y)10.37%
ROIC(5y)N/A
ROICexc(3y)13.79%
ROICexc(5y)N/A
ROICexgc(3y)19.27%
ROICexgc(5y)N/A
ROCE(3y)14.31%
ROCE(5y)N/A
ROICexcg growth 3Y22.07%
ROICexcg growth 5Y40.08%
ROICexc growth 3Y16.88%
ROICexc growth 5Y36.18%
OM growth 3Y13.3%
OM growth 5Y31.4%
PM growth 3Y10.38%
PM growth 5Y85.26%
GM growth 3Y0.06%
GM growth 5Y0.84%
F-Score8
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.01
Debt/EBITDA 0
Cap/Depr 107.25%
Cap/Sales 3.42%
Interest Coverage 58.35
Cash Conversion 79.18%
Profit Quality 89.82%
Current Ratio 1.36
Quick Ratio 1.1
Altman-Z N/A
F-Score8
WACC7.09%
ROIC/WACC1.63
Cap/Depr(3y)96.01%
Cap/Depr(5y)83.18%
Cap/Sales(3y)3.22%
Cap/Sales(5y)3.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.6%
EPS 3Y25.19%
EPS 5Y96.42%
EPS Q2Q%15.38%
EPS Next Y18.02%
EPS Next 2Y16.09%
EPS Next 3Y14.61%
EPS Next 5Y12.18%
Revenue 1Y (TTM)14.42%
Revenue growth 3Y13.35%
Revenue growth 5Y5.98%
Sales Q2Q%13.06%
Revenue Next Year8.08%
Revenue Next 2Y7.33%
Revenue Next 3Y7.1%
Revenue Next 5Y6.04%
EBIT growth 1Y29.71%
EBIT growth 3Y28.43%
EBIT growth 5Y39.26%
EBIT Next Year64.77%
EBIT Next 3Y25.33%
EBIT Next 5Y14.07%
FCF growth 1Y0.15%
FCF growth 3Y3.15%
FCF growth 5YN/A
OCF growth 1Y15.52%
OCF growth 3Y8.72%
OCF growth 5Y35.97%